1832 Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-25
| Closed | -$2.97K | – | 806 |
|
2024
Q2 | $2.97K | Buy |
+25
| New | +$2.97K | ﹤0.01% | 823 |
|
2023
Q4 | – | Sell |
-10,913
| Closed | -$1.13M | – | 880 |
|
2023
Q3 | $1.13M | Sell |
10,913
-5,244
| -32% | -$542K | ﹤0.01% | 557 |
|
2023
Q2 | $1.96M | Buy |
16,157
+528
| +3% | +$64.2K | ﹤0.01% | 491 |
|
2023
Q1 | $2.4M | Buy |
15,629
+15,614
| +104,093% | +$2.4M | ﹤0.01% | 483 |
|
2022
Q4 | $2.69K | Hold |
15
| – | – | ﹤0.01% | 850 |
|
2022
Q3 | $2K | Sell |
15
-27,500
| -100% | -$3.67M | ﹤0.01% | 844 |
|
2022
Q2 | $3.93M | Buy |
27,515
+27,500
| +183,333% | +$3.93M | 0.01% | 416 |
|
2022
Q1 | $3K | Buy |
+15
| New | +$3K | ﹤0.01% | 877 |
|
2021
Q4 | – | Sell |
-2,426
| Closed | -$925K | – | 812 |
|
2021
Q3 | $925K | Buy |
+2,426
| New | +$925K | ﹤0.01% | 496 |
|